Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Lipigon Pharmaceuticals AB (publ)
  6. News
  7. Summary
    LPGO   SE0015382072

LIPIGON PHARMACEUTICALS AB (PUBL)

(LPGO)
SummaryQuotesChartsNewsCalendarCompanyFinancials 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about LIPIGON PHARMACEUTICALS AB (PUBL)
01/14Lipigon Pharmaceuticals AB Completes Another Preclinical Study with Drug Candidate Lipi..
CI
2021Lipigon Announces Positive Results from Preclinical Study for Lipid-Lowering Drug Candi..
CI
2021Lipigon Pharmaceuticals AB Reports Earnings Results for the Third Quarter and Nine Mont..
CI
2021Lipigon Pharmaceuticals AB and 5Prime Sciences Enter Partnership to Optimize Coming Cli..
CI
2021Lipigon Pharmaceuticals AB Publ Reports Earnings Results for the Second Quarter Ended J..
CI
2021Lipigon Pharmaceuticals AB cancelled the acquisition of antisense drug candidates and p..
CI
2021Lipigon Pharmaceuticals AB has completed an IPO in the amount of SEK 50.007395 million.
CI
2021Lipigon Pharmaceuticals AB has filed an IPO in the amount of SEK 50.007395 million.
CI
2020Lipigon Pharmaceuticals AB signed a research, development, and transfer agreement to ac..
CI
2016Lipigon Pharmaceuticals AB announced that it has received funding from Almi Invest AB
CI
More most relevant news
All news about LIPIGON PHARMACEUTICALS AB (PUBL)
01/14Lipigon Pharmaceuticals AB Completes Another Preclinical Study with Drug Candidate Lipi..
CI
2021Lipigon Announces Positive Results from Preclinical Study for Lipid-Lowering Drug Candi..
CI
2021Lipigon Pharmaceuticals AB Reports Earnings Results for the Third Quarter and Nine Mont..
CI
2021Lipigon Pharmaceuticals AB and 5Prime Sciences Enter Partnership to Optimize Coming Cli..
CI
2021Lipigon Pharmaceuticals AB Publ Reports Earnings Results for the Second Quarter Ended J..
CI
2021Lipigon Pharmaceuticals AB cancelled the acquisition of antisense drug candidates and p..
CI
2021Lipigon Pharmaceuticals AB has completed an IPO in the amount of SEK 50.007395 million.
CI
2021Lipigon Pharmaceuticals AB has filed an IPO in the amount of SEK 50.007395 million.
CI
2020Lipigon Pharmaceuticals AB signed a research, development, and transfer agreement to ac..
CI
2016Lipigon Pharmaceuticals AB announced that it has received funding from Almi Invest AB
CI
More news
News in other languages on LIPIGON PHARMACEUTICALS AB (PUBL)
01/14Lipigon Pharmaceuticals AB (Publ) achève une autre étude préclinique avec le candidat m..
More news
Upcoming event on LIPIGON PHARMACEUTICALS AB (PUBL)
02/23/22